Universityhospital Bern, Inselspital
Welcome,         Profile    Billing    Logout  
 0 Trials 
3 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Scheidegger, Olivier
ALKIVIA, NCT05523167 / 2021-001277-23: A Study to Investigate the Efficacy and Safety of Efgartigimod PH20 SC in Adult Participants with Active Idiopathic Inflammatory Myopathy.

Recruiting
2/3
240
Europe, Canada, Japan, US, RoW
EFG PH20 SC, PBO
argenx, argenx BV
Active Idiopathic Inflammatory Myopathy, Myositis, Dermatomyositis, Polymyositis, Immune-Mediated Necrotizing Myopathy, Antisynthetase Syndrome
12/26
02/27
TIDALS, NCT05105958: Tideglusib for the Treatment of Amyotrophic Lateral Sclerosis

Not yet recruiting
2
98
Europe
Tideglusib
University of Zurich, University of Lausanne Hospitals, University of Bern, Cantonal Hospital of St. Gallen, University Hospital, Geneva
Amyotrophic Lateral Sclerosis
12/25
03/26
Swiss-Reg-NMD, NCT05102916: Swiss Registry for Neuromuscular Disorders

Recruiting
N/A
2000
Europe
University of Bern, University Children's Hospital Basel, Insel Gruppe AG, University Hospital Bern, University of Lausanne Hospitals, Ente Ospedaliero Cantonale, Bellinzona, University Children's Hospital, Zurich
SMA, DMD, BMD, IMD, Congenital Muscular Dystrophy
01/71
01/71

Download Options